These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24040982)

  • 1. [Position of targeted therapy in ovarian cancer management].
    Majirský M; Kubecová M; Kindlová E; Tikovský K
    Ceska Gynekol; 2013 Aug; 78(4):347-50. PubMed ID: 24040982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapies for Ovarian Cancer.
    O'Malley DM
    J Natl Compr Canc Netw; 2019 May; 17(5.5):619-621. PubMed ID: 31117037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in ovarian cancer.
    Lim HJ; Ledger W
    Womens Health (Lond); 2016 Jun; 12(3):363-78. PubMed ID: 27215391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of targeted therapy in ovarian cancer.
    Banerjee S; Kaye S
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S116-30. PubMed ID: 21943965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy of ovarian cancer including immune check point inhibitor.
    Kim JY; Cho CH; Song HS
    Korean J Intern Med; 2017 Sep; 32(5):798-804. PubMed ID: 28823141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors.
    Duan P; Fan L; Gao Q; Silwal BM; Ren M; Shen Y; Qu W
    Curr Drug Targets; 2017; 18(10):1171-1178. PubMed ID: 28443505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapies for Ovarian Cancer.
    Grunewald T; Ledermann JA
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():139-152. PubMed ID: 28111228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review.
    Poonawalla IB; Parikh RC; Du XL; VonVille HM; Lairson DR
    Pharmacoeconomics; 2015 Nov; 33(11):1155-85. PubMed ID: 26072142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guideline for gynecological malignant tumors I. Standard--a complex therapy of ovarian epithelial malignant tumors].
    Robová H; Rob L; Svoboda B; Fínek J; Safár P; Spacek J; Petruzelka L; Chovanec J;
    Ceska Gynekol; 2006 May; 71(3):237-46. PubMed ID: 16768053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S; Hoskins WJ
    Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis: a promising therapeutic target for ovarian cancer.
    Bamias A; Pignata S; Pujade-Lauraine E
    Crit Rev Oncol Hematol; 2012 Dec; 84(3):314-26. PubMed ID: 22575381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of epithelial ovarian cancer].
    Langmár Z; Csömör S
    Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current controversies in the management of germ cell ovarian tumours.
    Vazquez I; Rustin GJ
    Curr Opin Oncol; 2013 Sep; 25(5):539-45. PubMed ID: 23942298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of advanced stage ovarian cancer].
    Morice P; Camatte S; Lhomme C; Duvillard P; Castaigne D
    Rev Prat; 2004 Oct; 54(16):1777-86. PubMed ID: 15630882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant ascites in ovarian cancer and the role of targeted therapeutics.
    Smolle E; Taucher V; Haybaeck J
    Anticancer Res; 2014 Apr; 34(4):1553-61. PubMed ID: 24692682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
    Matković V; Haller H; Vrdoljak E; Corusić A; Jelavić TB; Strinić T; Karnjus-Begonja R; Barisic D; Tomić S; Kukura V; Ban M; Ranka SP; Matic M; Skalec SL; Topolovec Z; Mrcela M; Zekan J; Fröbe A; Hajredini A; Babic D; Mamula O; Brncić-Fischer A; Vojnović Z; Sundov D; ; ;
    Lijec Vjesn; 2013; 135(9-10):235-41. PubMed ID: 24364199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innovations in the treatment of ovarian cancer. Analysis of the therapeutic development: from platinum to immunotherapy.].
    Angius G; Sepe P; Papa A; Tomao S; Tomao F
    Recenti Prog Med; 2017 Jun; 108(6):269-281. PubMed ID: 28631775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.